Tofacitinib as treatment for refractory dermatomyositis: A retrospective study from 2 academic medical centers
Author:
Funder
Dermatology Foundation
Publisher
Elsevier BV
Subject
Dermatology
Reference5 articles.
1. JAK inhibitors in dermatology: the promise of a new drug class;Damsky;J Am Acad Dermatol,2017
2. Tofacitinib citrate for refractory cutaneous dermatomyositis: an alternative treatment;Kurtzman;JAMA Dermatol,2016
3. The relationship between JAK2(V617F) mutation and dermatomyositis—a case report and literature review;Xu;Clin Rheumatol,2021
4. Validation of the cutaneous dermatomyositis disease area and severity index: characterizing disease severity and assessing responsiveness to clinical change;Anyanwu;Br J Dermatol,2015
5. Morbidity and mortality in adult polymyositis and dermatomyositis;Marie;Curr Rheumatol Rep,2012
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Successful treatment of refractory amyopathic dermatomyositis with upadacitinib in prior JAK inhibitor failure;JAAD Case Reports;2024-09
2. Current evidence for janus kinase inhibitors in adult and juvenile dermatomyositis and key comparisons;Expert Opinion on Pharmacotherapy;2024-08-12
3. Effectiveness of generic tofacitinib in idiopathic inflammatory myositis (IIM)—a retrospective analysis from Indian Myositis Registry (MyoIN);Clinical Rheumatology;2024-06-03
4. Therapeutic efficacy and safety of JAK inhibitors in treating polymyositis/dermatomyositis: a single-arm systemic meta-analysis;Frontiers in Immunology;2024-03-21
5. Anti-synthetase syndrome is associated with a higher risk of hospitalization among patients with idiopathic inflammatory myopathy and COVID-19;Frontiers in Immunology;2024-03-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3